186 related articles for article (PubMed ID: 28380418)
1. Expression of EMT markers and mode of surgery are prognostic in phyllodes tumors of the breast.
Feng X; Zhao L; Shen H; Liu X; Yang Y; Lv S; Niu Y
Oncotarget; 2017 May; 8(20):33365-33374. PubMed ID: 28380418
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of epithelial-mesenchymal transition proteins Twist and Foxc2 in phyllodes tumours of the breast.
Lim JC; Koh VC; Tan JS; Tan WJ; Thike AA; Tan PH
Breast Cancer Res Treat; 2015 Feb; 150(1):19-29. PubMed ID: 25677742
[TBL] [Abstract][Full Text] [Related]
3. Expression of EMT inducers integrin-linked kinase (ILK) and ZEB1 in phyllodes breast tumors is associated with aggressive phenotype.
Akrida I; Nikou S; Gyftopoulos K; Argentou M; Kounelis S; Zolota V; Bravou V; Papadaki H
Histol Histopathol; 2018 Sep; 33(9):937-949. PubMed ID: 29608014
[TBL] [Abstract][Full Text] [Related]
4. Molecules involved in epithelial-mesenchymal transition and epithelial-stromal interaction in phyllodes tumors: implications for histologic grade and prognosis.
Kwon JE; Jung WH; Koo JS
Tumour Biol; 2012 Jun; 33(3):787-98. PubMed ID: 22203494
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin expression in the epithelial components of mammary phyllodes tumors.
Tsang JY; Mendoza P; Putti TC; Karim RZ; Scolyer RA; Lee CS; Pang AL; Tse GM
Hum Pathol; 2012 Dec; 43(12):2117-23. PubMed ID: 22820000
[TBL] [Abstract][Full Text] [Related]
6. Expression of cancer stem cell markers in breast phyllodes tumor.
Kim SI; Koo JS
Cancer Biomark; 2020; 29(2):235-243. PubMed ID: 32675396
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic analysis of benign, borderline and malignant phyllodes tumors of the breast].
Wang H; Wang X; Wang C
Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):923-7. PubMed ID: 26887622
[TBL] [Abstract][Full Text] [Related]
8. Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors.
Abe M; Miyata S; Nishimura S; Iijima K; Makita M; Akiyama F; Iwase T
Breast Cancer; 2011 Oct; 18(4):268-72. PubMed ID: 22121516
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome.
Onkendi EO; Jimenez RE; Spears GM; Harmsen WS; Ballman KV; Hieken TJ
Ann Surg Oncol; 2014 Oct; 21(10):3304-9. PubMed ID: 25034817
[TBL] [Abstract][Full Text] [Related]
10. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.
Taira N; Takabatake D; Aogi K; Ohsumi S; Takashima S; Nishimura R; Teramoto N
Jpn J Clin Oncol; 2007 Oct; 37(10):730-6. PubMed ID: 17932112
[TBL] [Abstract][Full Text] [Related]
11. High expression of microRNA20b is associated with malignant clinicopathological features and poor prognosis in breast phyllodes tumor.
Lei T; Yin L; Zhang H; Wei B; Chen H; Pu T; Yang L; Ye F; Zhang Z; Bu H
Int J Clin Oncol; 2020 Dec; 25(12):2025-2034. PubMed ID: 32803488
[TBL] [Abstract][Full Text] [Related]
12. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration.
Kim GE; Kim NI; Park MH; Lee JS
Tumour Biol; 2018 Nov; 40(11):1010428318815032. PubMed ID: 30486739
[TBL] [Abstract][Full Text] [Related]
13. Expression of EMT Markers SLUG and TWIST in Breast Cancer.
Grzegrzolka J; Biala M; Wojtyra P; Kobierzycki C; Olbromski M; Gomulkiewicz A; Piotrowska A; Rys J; Podhorska-Okolow M; Dziegiel P
Anticancer Res; 2015 Jul; 35(7):3961-8. PubMed ID: 26124343
[TBL] [Abstract][Full Text] [Related]
14. Molecular classification of breast phyllodes tumors: validation of the histologic grading scheme and insights into malignant progression.
Ang MK; Ooi AS; Thike AA; Tan P; Zhang Z; Dykema K; Furge K; Teh BT; Tan PH
Breast Cancer Res Treat; 2011 Sep; 129(2):319-29. PubMed ID: 20945089
[TBL] [Abstract][Full Text] [Related]
15. Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast.
Yonemori K; Hasegawa T; Shimizu C; Shibata T; Matsumoto K; Kouno T; Ando M; Katsumata N; Fujiwara Y
Pathol Res Pract; 2006; 202(10):705-12. PubMed ID: 16889904
[TBL] [Abstract][Full Text] [Related]
16. Analysis of phyllodes tumor recurrence according to the histologic grade.
Kim S; Kim JY; Kim DH; Jung WH; Koo JS
Breast Cancer Res Treat; 2013 Oct; 141(3):353-63. PubMed ID: 24062207
[TBL] [Abstract][Full Text] [Related]
17. Pediatric Malignant Phyllodes Tumors of the Breast: Characteristics and Outcomes Based on the Surveillance Epidemiology and End Results Database.
Xiao Y; Jiang Y; Xiong Y; Ruan S; Huang T
J Surg Res; 2020 May; 249():205-215. PubMed ID: 31991330
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Molecular and Biological Characteristics of Phyllodes Tumors of the Breast.
Vorotnikov IK; Vysotskaya IV; Denchik DA; Letyagin VP; Davydov MM; Kirsanov VY; Kim EA; Buseva VS
Bull Exp Biol Med; 2020 Oct; 169(6):806-810. PubMed ID: 33098518
[TBL] [Abstract][Full Text] [Related]
19. The clinical features and prognosis of phyllodes tumors: a single institution experience in Taiwan.
Lin CC; Chang HW; Lin CY; Chiu CF; Yeh SP
Int J Clin Oncol; 2013 Aug; 18(4):614-20. PubMed ID: 22773245
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients.
van Nes JG; de Kruijf EM; Putter H; Faratian D; Munro A; Campbell F; Smit VT; Liefers GJ; Kuppen PJ; van de Velde CJ; Bartlett JM
Breast Cancer Res Treat; 2012 May; 133(1):49-59. PubMed ID: 21796367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
